Cellectis Reports Financial Results for First Quarter 2024 :

• Cellectis announced completion of the additional equity investment of $140M by AstraZeneca

Related Keywords

United Kingdom , North Carolina , United States , France , Paris , France General , Raleigh , New York , Marc Dunoyer , Patricia Sosa Navarro , Arthur Stril , Ashleyr Robinson , Pascalyne Wilson , Bing Wang , Astrazeneca , Research Plan , Allogeneic Car Development Programs , Group Share , International Accounting Standards Board , Nasdaq , European Union , Securities Exchange Commission , International Financial Reporting Standards , Cellectis The Company Euronext Growth , Euronext Growth , Chief Executive Officer , Development Programs , Investment Agreements , Interim Chief Financial Officer , Tyrell Rivers , Subsequent Investment Agreement , Net Income , Regarding Use , Nasdaq Global Market , Private Securities Litigation Reform Act , Annual Report , Sosa Navarro , Lifesci Advisors ,